The PhosphorusONE genetic test is the first genetic test that provides a holistic approach to aging. Understand your predisposition for neurodegenerative disease, vision loss, hearing loss and more, and begin to act sooner so that you can age more gracefully.
Read MoreThe PhosphorusONE genetic test looks at 83 genes that affect your ability to metabolize nearly 200 medications. These drugs are used to treat everything from blood clots to depression – and some of them work better for you than others. Learn how analyzing your DNA can help make sure you’re getting the most out of your medications.
Read MoreSequencing and Genotyping are two methods for looking at your genetic code. Both make use of the latest technologies from companies like Affymetrix, Illumina, and Pacific Biosciences, yet there are major differences in how these technologies look at the genome.
Read MoreIt’s time to leverage this powerful genomic technology to help improve lives. Learn how the PhosphorusONE test can help you take control of your genomic health.
Read MoreThe new genetic test targets over 20 genes associated with familial hypercholesterolemia (FH), hypobetalipoproteinemia, familial chylomicronemia, familial hypertriglyceridemia, and disorders of lipid metabolism.
Read MoreThe company's ophthalmologic tests can help guide vision loss management and complications from eye surgery. The pharmacogenomic test can help reduce the risk of adverse events from drugs.
Read MoreThe tests are designed to provide clarity on lifetime risk and drastically improve survival rates across cancer types.
Read MoreThe tests can help affected patients and family members guide disease management to prevent severe cardiac events, such as heart attack or sudden death.
Read MorePhosphorus is a genomics company working to improve human health. Our best-in-class genetic tests have helped thousands of people avoid disease and live healthier lives. CEO Alex Bisignano explains the meaning behind the name.
Read MoreFinancing led by FirstMark Capital will fuel expansion of cloud-based genome and lab management software and the launch of clinical genetic tests.
Read More
